Colgate-Palmolive Company

(New York Stock Exchange)
Back to all articles
Somewhat Bullish +40

Colgate-Palmolive stock trades at USD 86.06 after dividend update

Dividend Earnings report AI-generated analysis

πŸ“ˆ Colgate-Palmolive reported Q2 net sales of USD 5.361 billion, up 4.9% year over year.

πŸ’° GAAP EPS declined 5% to USD 0.86, while Base Business EPS increased 8% to USD 0.99.

πŸ“‰ Gross margin improved by 140 basis points to reach 61.5% in the second quarter.

🌍 Emerging markets and Hill's Pet Nutrition served as primary growth contributors for the quarter.

πŸ‡ΊπŸ‡Έ North American business faced headwinds from retailer inventory reductions and softer premium oral-care demand.

πŸ“Š Management raised full-year gross-margin guidance to flat despite mixed regional performance.

πŸ’΅ The company declared a quarterly dividend of USD 0.53 payable on November 13, 2026.

πŸ“‰ Piper Sandler analyst cut its price target from USD 98 to USD 95 while keeping an Overweight rating.

🎯 The 19-analyst average price target stands at USD 98.94 as of September 25, 2026.

πŸ“ˆ Stock traded at USD 86.06, trading 13.27% below the 52-week high of USD 99.33.

Bullish Signals
  • Colgate-Palmolive achieved a gross margin of 61.5%, representing a significant 140-basis-point improvement over prior periods.
  • Base Business EPS increased 8% to USD 0.99, demonstrating underlying operational strength despite GAAP headwinds.
  • Net sales grew 4.9% year over year to USD 5.361 billion, driven by volume growth in emerging markets.
  • Hill's Pet Nutrition contributed meaningfully to overall revenue growth during the second quarter.
  • Management raised full-year gross-margin guidance to flat, signaling confidence in margin expansion capabilities.
  • The company maintains a long history of uninterrupted common-stock dividends since 1895, reinforcing its status as a reliable income stock.
Risk Factors
  • GAAP EPS declined 5% to USD 0.86 due to non-base business factors and currency impacts.
  • North American business faced specific headwinds including retailer inventory reductions and market-share pressure.
  • Demand for premium oral-care products softened in the North American region during the quarter.
  • Piper Sandler analyst cut its price target from USD 98 to USD 95, reflecting concerns about near-term execution.
  • The stock trades 13.27% below its 52-week high, indicating some market skepticism regarding current valuation.
Full Analysis
Colgate-Palmolive reported second-quarter 2026 results with net sales of USD 5.361 billion, representing a 4.9% year-over-year increase. GAAP earnings per share declined 5% to USD 0.86, while Base Business EPS rose 8% to USD 0.99. The company achieved a gross margin of 61.5%, reflecting a significant 140-basis-point improvement driven by operational efficiency and pricing strategies. Management highlighted strong contributions from emerging markets and Hill's Pet Nutrition as key growth drivers during the quarter. However, the North American business faced headwinds including retailer inventory reductions, market-share pressure, and softer demand for premium oral-care products. Consequently, management described second-half growth expectations as more volume-driven and raised full-year gross-margin guidance to remain flat. Following the earnings release, Colgate-Palmolive stock traded at USD 86.06 on September 25, 2026, standing 13.27% below its 52-week high. Analyst sentiment remains mixed; Piper Sandler cut its price target to USD 95 while maintaining an Overweight rating, whereas the broader analyst consensus average target sits at USD 98.94. The market debate centers on whether international expansion and margin execution can sufficiently offset the weaker performance in North America. Colgate-Palmolive maintains a long history of uninterrupted common-stock dividends since 1895, with a quarterly dividend of USD 0.53 declared for shareholders of record on October 20, 2026. With a market capitalization of USD 68.9 billion, the stock trades within its 52-week range of USD 74.55 to USD 99.33, offering investors exposure to a defensive consumer staple with improving margins but mixed regional outlooks.